| Nanoparticles for drug delivery: the need for precision in reporting particle size parameters M Gaumet, A Vargas, R Gurny, F Delie European journal of pharmaceutics and biopharmaceutics 69 (1), 1-9, 2008 | 1330 | 2008 |
| A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model F Delie, W Rubas Critical Reviews™ in Therapeutic Drug Carrier Systems 14 (3), 1997 | 573 | 1997 |
| Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles JL Bourges, SE Gautier, F Delie, RA Bejjani, JC Jeanny, R Gurny, ... Investigative ophthalmology & visual science 44 (8), 3562-3569, 2003 | 473 | 2003 |
| The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems A Vargas, M Zeisser-Labouèbe, N Lange, R Gurny, F Delie Advanced drug delivery reviews 59 (11), 1162-1176, 2007 | 397 | 2007 |
| Evaluation of nano-and microparticle uptake by the gastrointestinal tract F Delie Advanced drug delivery reviews 34 (2-3), 221-233, 1998 | 289 | 1998 |
| Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells AMM Sadeghi, FA Dorkoosh, MR Avadi, M Weinhold, A Bayat, F Delie, ... European journal of pharmaceutics and biopharmaceutics 70 (1), 270-278, 2008 | 239 | 2008 |
| Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer M Zeisser-Labouèbe, N Lange, R Gurny, F Delie International journal of pharmaceutics 326 (1-2), 174-181, 2006 | 226 | 2006 |
| Polymeric particulates to improve oral bioavailability of peptide drugs F Delie, MJ Blanco-Príeto Molecules 10 (1), 65-80, 2005 | 221 | 2005 |
| Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos A Vargas, B Pegaz, E Debefve, Y Konan-Kouakou, N Lange, JP Ballini, ... International journal of pharmaceutics 286 (1-2), 131-145, 2004 | 212 | 2004 |
| Differential tumor cell targeting of anti-HER2 (Herceptin®) and anti-CD20 (Mabthera®) coupled nanoparticles A Cirstoiu-Hapca, L Bossy-Nobs, F Buchegger, R Gurny, F Delie International journal of pharmaceutics 331 (2), 190-196, 2007 | 163 | 2007 |
| Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size M Gaumet, R Gurny, F Delie European Journal of Pharmaceutical Sciences 36 (4-5), 465-473, 2009 | 134 | 2009 |
| Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice A Cirstoiu-Hapca, F Buchegger, N Lange, L Bossy, R Gurny, F Delie Journal of Controlled Release 144 (3), 324-331, 2010 | 127 | 2010 |
| Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells A Cirstoiu-Hapca, F Buchegger, L Bossy, M Kosinski, R Gurny, F Delie European Journal of Pharmaceutical Sciences 38 (3), 230-237, 2009 | 98 | 2009 |
| Fluorescent biodegradable PLGA particles with narrow size distributions: preparation by means of selective centrifugation M Gaumet, R Gurny, F Delie International journal of pharmaceutics 342 (1-2), 222-230, 2007 | 82 | 2007 |
| In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome A Vargas, M Eid, M Fanchaouy, R Gurny, F Delie European journal of pharmaceutics and biopharmaceutics 69 (1), 43-53, 2008 | 74 | 2008 |
| Characterization of V3 BRU peptide-loaded small PLGA microspheres prepared by a (w1/o) w2 emulsion solvent evaporation method MJB Prieto, F Delie, E Fattal, A Tartar, F Puisieux, A Gulik, P Couvreur International journal of pharmaceutics 111 (2), 137-145, 1994 | 70 | 1994 |
| GRP78 protein expression in ovarian cancer patients and perspectives for a drug-targeting approach F Delie, P Petignat, M Cohen Journal of oncology 2012, 2012 | 67 | 2012 |
| Comparison of two methods of encapsulation of an oligonucleotide into poly (D, L-lactic acid) particles F Delie, M Berton, E Allémann, R Gurny International journal of pharmaceutics 214 (1-2), 25-30, 2001 | 65 | 2001 |
| PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In Vitro and In Ovo assessment AI Fraguas-Sánchez, AI Torres-Suárez, M Cohen, F Delie, D Bastida-Ruiz, ... Pharmaceutics 12 (5), 439, 2020 | 63 | 2020 |
| Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly (lactide-co-glycolide) microspheres prepared by a W/O/W solvent … MJ Blanco-Príeto, E Leo, F Delie, A Gulik, P Couvreur, E Fattal Pharmaceutical research 13 (7), 1127-1129, 1996 | 62 | 1996 |
Olivier JordanSenior lecturer, University of GenevaVerified email at unige.ch
